Research Paper Volume 16, Issue 3 pp 2410—2437
A novel PANoptosis-related long non-coding RNA index to predict prognosis, immune microenvironment and personalised treatment in hepatocellular carcinoma
Figure 10. PANRI-based drug sensitivity analysis. (A–O) Box plots show that the IC50 for certain clinical therapeutics differed significantly between the two risk subgroups (p < 0.001).